CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$1.43
Tradestie Score
49
Market Cap
$330.07M
Revenue Growth
-0.6%
Analyst Upside
+272.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
MCRB
Seres Therapeutics, Inc.
|
$2.94
|
$179.47M | - | 47 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.99
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.24
|
$158.43M | - | 44 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.92
|
$154.27M | - | 68 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$2.32
|
$144.16M | - | 39 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.73
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.80
|
$110.20M | - | 61 | Compare |
|
ATRA
Atara Biotherapeutics, Inc
|
$9.48
|
$101.48M | - | 44 | Compare |
More CLLS Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry